| Pralmorelin Basic information |
| Product Name: | Pralmorelin |
| Synonyms: | d-ala-β-(2-naphthyl)-d-ala-trp-d-phe-lys amide;L-Lysinamide, D-alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-;PRALMORELIN;D-ALA-D-NAL(2)-ALA-TRP-D-PHE-LYS-NH2 ACETATE SALT;D-ALA-BETA-(2-NAPHTHYL)-D-ALA-TRP-D-PHE-LYS AMIDE;D-ALA-D-2-NAL-ALA-TRP-D-PHE-LYS-NH2;(DES-ALA3,D-ALA1,D-2-NAL2)-GHRP-6;(DES-ALA3)-GHRP-2 |
| CAS: | 158861-67-7 |
| MF: | C45H55N9O6 |
| MW: | 817.97 |
| EINECS: | 206-616-8 |
| Product Categories: | Peptide;Peptides;GHRP2;hgh;158861-67-7 |
| Mol File: | 158861-67-7.mol |
 |
|
| Pralmorelin Chemical Properties |
| Melting point | 149 - 151°C |
| Boiling point | 1265.3±65.0 °C(Predicted) |
| density | 1.270±0.06 g/cm3(Predicted) |
| storage temp. | −20°C |
| solubility | DMSO (Slightly, Sonicated), Water (Slightly) |
| pka | 13.40±0.46(Predicted) |
| form | lyophilized powder |
| color | white to beige |
| Stability: | Hygroscopic |
| InChIKey | HRNLPPBUBKMZMT-RDRUQFPZSA-N |
| CAS DataBase Reference | 158861-67-7(CAS DataBase Reference) |
| Safety Information |
| Pralmorelin Usage And Synthesis |
| Description | Pralmorelin (also known as KP-102, GPA-748, GHRP-2) is a potent GH secretagogue in development as a diagnostic agent for growth hormone deficiency and for the treatment of pituitary disorders and GH deficiency. It acts as a Signal molecules that are involved in the control of cell growth and differentiation. |
| Uses | Growth hormone releasing factor. Pralmorelin is a growth hormone secretagogue that acts on the pituitary gland and the hypothalamus to stimulate and amplify pulsatile growth hormone release. |
| Biochem/physiol Actions | Pralmorelin, also known as Growth hormone-releasing peptide 2 or GHRP-2, is an orally-active, synthetic peptide analogue of met-enkephalin that acts as a ghrelin/growth hormone secretagogue receptor (GHSR) agonist to selectively stimulate the ghrelin receptor and cause growth hormone release. Pralmorelin (GHRP-2) has been used clinically for the assessment of growth hormone deficiency (GHD), It has also been shown to have anti-inflammatory activity. |
